This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The mediodorsal nucleus of the thalamus (MDT) is one of the largest thalamic nuclei and is a typical association nucleus, participating in several cortico-subcortical networks, primarily those involving the prefrontal cortex.1–3 Pathologic involvement of the MDT or its cortical connections contributes to the cognitive, emotional, and behavioral manifestations of stroke4–6; metabolic disorders, such as Wernicke encephalopathy7; inflammatory disorders, such as multiple sclerosis8; prion disorders, such as fatal familial insomnia9 and Creutzfeldt-Jakob disease10; and neurodegenerative diseases, such as Alzheimer disease,11 dementia with Lewy bodies,12 and Parkinson disease.13 The MDT also participates in the pathophysiology of epilepsy14,15 and schizophrenia.16 The following case shows that its involvement affects wide cortical areas and produces disabling symptoms that may not be associated with objective abnormalities in neuropsychometric testing.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Mediodorsal nucleus and confabulations
- Author response to Dr. Onofrj
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
